Rapid Microbiology Testing Market by Product (Instruments (Mass Spectrometers), Consumables), Method (Nucleic Acid-based), Application (Industrial Testing (Food & Beverage), Clinical Diagnosis), End User (Hospitals), & Region - Global Forecast to 2031

icon1
USD 9.00 BN
MARKET SIZE, 2031
icon2
CAGR 9.6%
(2026-2031)
icon3
380
REPORT PAGES
icon4
410
MARKET TABLES

OVERVIEW

rapid-microbiology-testing-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The rapid microbiology testing market is projected to reach USD 9.00 billion by 2031 from USD 5.69 billion in 2026, at a CAGR of 9.6%. The rapid microbiology testing market is driven by the rising prevalence of infectious diseases, increasing demand for faster microbial detection, growing pharmaceutical and biopharmaceutical production, and stringent contamination control regulations. Advancements in molecular diagnostics, automation technologies, and rapid sterility testing systems are further supporting market growth globally.

KEY TAKEAWAYS

  • BY REGION
    The Asia Pacific region is expected to witness the fastest growth in the rapid microbiology testing market, driven by expanding healthcare infrastructure, increasing pharmaceutical and biopharmaceutical manufacturing, and rising adoption of rapid molecular diagnostic technologies in countries such as China, India, Japan, and South Korea.
  • BY PRODUCT
    By product, reagents & kits accounted for the largest share of 52.4% in 2025, primarily due to their recurring usage across sterility testing, microbial identification, PCR assays, and contamination monitoring workflows in clinical and industrial settings.
  • BY METHOD
    By method, growth-based rapid microbiology testing accounted for the largest market share of 40.2% in 2025 due to its widespread use in pharmaceutical sterility testing, environmental monitoring, food safety testing, and clinical microbiology applications.
  • BY APPLICATION
    By application, the industrial testing segment accounted for the largest market share of 56.8% in 2025, supported by rising demand for sterility assurance, contamination control, and regulatory compliance in pharmaceuticals, food & beverages, and environmental testing industries.
  • BY END USER
    By end user, pharmaceutical & biotechnology companies are projected to witness the highest CAGR during the forecast period due to the increasing adoption of rapid sterility testing and microbial monitoring solutions in biopharmaceutical manufacturing and quality control processes.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    bioMérieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific, Inc. (US) were identified as star players, which correspondingly are supported by their strong market presence and extensive product portfolios.
  • COMPETITIVE LANDSCAPE - STARTUPS/SMEs
    Don Whitley Scientific Limited (UK), Gradientech (Sweden), Rqmicro AG (Switzerland), and Colifast AS (Norway) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.

The rapid microbiology testing market is experiencing growth due to the rising prevalence of infectious diseases, increasing incidence of healthcare-associated infections, and growing demand for faster microbial detection methods across healthcare and industrial settings. The expansion of pharmaceutical and biopharmaceutical manufacturing activities is increasing the need for rapid sterility testing and contamination control solutions. Additionally, advancements in molecular diagnostics, laboratory automation, PCR technologies, and automated microbial identification systems are improving testing efficiency and turnaround times.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The influence of end users on the rapid microbiology testing market is driven by the increasing demand for faster microbial detection, stringent contamination control requirements, and the growing adoption of automated diagnostic technologies. Key end users of rapid microbiology testing solutions include hospitals, clinical laboratories, pharmaceutical & biotechnology companies, food & beverage manufacturers, environmental testing laboratories, and research institutions. High-growth applications in this market include infectious disease diagnosis, sterility testing, antimicrobial susceptibility testing, pharmaceutical quality control, food safety testing, environmental monitoring, and biopharmaceutical manufacturing.

rapid-microbiology-testing-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
  • Technological advancements in automated microbiology and MALDI-TOF platforms
RESTRAINTS
Impact
Level
  • High capital investments and low cost-benefit ratio
  • Regulatory complexity and limited reimbursement coverage
OPPORTUNITIES
Impact
Level
  • Growing demand for rapid microbiology testing in emerging economies
  • Expansion of rapid microbial testing applications
CHALLENGES
Impact
Level
  • Workflow inefficiencies and skilled workforce shortages
  • High investment in automated microbial identification systems

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing prevalence of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases

The rising prevalence of healthcare-associated infections, antimicrobial-resistant pathogens, and infectious diseases is significantly increasing the demand for rapid microbiology testing solutions. Healthcare providers and pharmaceutical manufacturers are increasingly adopting rapid microbial detection technologies to enable faster diagnosis, improve infection control, and support timely treatment decisions.

Restraint: High capital investments and low cost-benefit ratio

The adoption of advanced rapid microbiology testing systems is often limited due to high capital investment requirements associated with automated instruments, molecular diagnostic platforms, and laboratory automation infrastructure. In addition, maintenance costs, software integration expenses, and the need for skilled laboratory personnel can increase operational costs, particularly for small and mid-sized laboratories.

Opportunity: Growing demand for rapid microbiology testing in emerging economies

Emerging economies present significant growth opportunities for the rapid microbiology testing market due to expanding healthcare infrastructure, increasing pharmaceutical manufacturing activities, and rising awareness regarding infection control and product safety. Governments and private healthcare organizations in countries such as China, India, Brazil, and Southeast Asian nations are investing heavily in laboratory modernization and molecular diagnostics. Increasing food safety concerns, growing biopharmaceutical production, and rising healthcare expenditure are further expected to drive market expansion in these regions.

Challenge: Workflow inefficiencies and skilled workforce shortages

Operational challenges such as complex laboratory workflows, lack of trained microbiology professionals, and difficulties in integrating advanced rapid testing systems with existing laboratory infrastructure may hinder market growth. In addition, variability in regulatory requirements, validation procedures, and quality assurance standards across regions can create implementation challenges for manufacturers and end users.

RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides automated microbial identification, antimicrobial susceptibility testing, rapid sterility testing, and molecular microbiology solutions for clinical diagnostics and pharmaceutical quality control applications Enables faster pathogen identification | Improved infection control | Reduced turnaround times | Enhanced regulatory compliance for healthcare and industrial laboratories
Uses MALDI-TOF mass spectrometry platforms for rapid microbial identification in clinical microbiology and pharmaceutical testing laboratories Delivers high-throughput microbial identification with improved accuracy | Lower per-test costs | Faster laboratory workflows compared to conventional culture-based methods
Offers molecular diagnostic systems, automated microbiology instruments, and rapid pathogen detection solutions through its life sciences and diagnostics businesses Supports rapid detection of infectious pathogens | Enhances laboratory automation | Improves operational efficiency in hospitals and research laboratories
Develops rapid molecular diagnostic and PCR-based microbiology testing systems for infectious disease detection and antimicrobial resistance monitoring Improves diagnostic accuracy | Accelerates clinical decision-making | Supports timely treatment interventions in healthcare settings
Provides PCR systems, culture media, microbial identification platforms, sterility testing solutions, and environmental monitoring products for healthcare and industrial applications Enhances contamination detection | Supports rapid product release in pharmaceutical manufacturing | Improves microbiology laboratory productivity and quality assurance processes

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The rapid microbiology testing ecosystem comprises manufacturers, distributors, and end users, each playing a critical role in delivering rapid microbial detection and identification solutions. Manufacturers develop and commercialize rapid microbiology instruments, molecular testing systems, and integrated diagnostic platforms. Distributors support product availability and market reach through their global distribution networks. End users, including hospitals, clinical laboratories, pharmaceutical and biotechnology companies, food & beverage manufacturers, and environmental testing laboratories utilize these solutions to accelerate pathogen detection, ensure product quality, support regulatory compliance, and improve operational efficiency.

rapid-microbiology-testing-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

rapid-microbiology-testing-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Rapid Microbiology Testing Market, by Product

In 2025, reagents & kits held the largest share of the rapid microbiology testing market and are expected to maintain their dominance through 2026. This is primarily driven by the recurring demand for culture media, assay kits, primers, probes, stains, and antimicrobial susceptibility testing reagents used in routine microbiology workflows. Increasing testing volumes across hospitals, pharmaceutical companies, and food testing laboratories, along with the growing adoption of molecular microbiology and automated testing platforms, continue to support long-term segmental growth globally.

Rapid Microbiology Testing Market, by Method

In 2025, the growth-based rapid microbiology testing method accounted for the largest market share due to the extensive use of this method in sterility testing, environmental monitoring, and microbial contamination detection. These methods are widely adopted because of their strong regulatory acceptance, reliability in detecting viable microorganisms, and compatibility with pharmaceutical quality assurance workflows.

Rapid Microbiology Testing Market, by Application

In 2025, the industrial testing application captured the largest share of the rapid microbiology testing market, driven by increasing demand for sterility assurance, contamination monitoring, and quality control across pharmaceuticals, biopharmaceuticals, food & beverages, and environmental testing industries. Growing regulatory requirements related to product safety and microbial contamination prevention are accelerating the adoption of rapid microbiology technologies. In addition, rising pharmaceutical manufacturing activities and increasing focus on operational efficiency are supporting sustained growth in industrial testing applications globally.

Rapid Microbiology Testing Market, by End User

In 2025, the hospitals, clinical laboratories, and ASCs segment held the largest share of the rapid microbiology testing market due to the rising demand for infectious disease testing and increasing prevalence of healthcare-associated infections. The growing adoption of rapid microbial identification systems, molecular diagnostics, and antimicrobial susceptibility testing solutions in healthcare settings is driving segmental growth. Additionally, increasing emphasis on early diagnosis, faster clinical decision-making, and improved patient outcomes continues to support demand for rapid microbiology testing technologies across hospitals and diagnostic laboratories globally.

REGION

Asia Pacific to be fastest-growing region in global rapid microbiology testing market during forecast period

The Asia Pacific region is expected to experience the highest CAGR in the rapid microbiology testing market from 2026 to 2031, driven by expanding healthcare infrastructure, increasing pharmaceutical and biopharmaceutical manufacturing activities, and rising adoption of rapid molecular diagnostic technologies. Countries such as China, India, Japan, and South Korea are witnessing significant investments in laboratory modernization, infection control programs, and healthcare automation, creating growth opportunities for the rapid microbiology testing market.

rapid-microbiology-testing-market Region

RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

In the rapid microbiology testing market, bioMérieux (France) stands out as a dominant player (Star) due to its strong portfolio of automated microbial identification systems, antimicrobial susceptibility testing platforms, molecular diagnostics solutions, and rapid sterility testing technologies. The company benefits from its extensive global presence; strong regulatory expertise; and broad customer base across hospitals, clinical laboratories, and pharmaceutical companies. In contrast, Bruker Corporation (US) is emerging leader through its expanding MALDI-TOF mass spectrometry portfolio, advanced microbial identification capabilities, and growing adoption in clinical and industrial microbiology laboratories. While bioMérieux maintains leadership through innovation and established microbiology expertise, Bruker continues to strengthen its market position through technological advancements and increasing penetration across diagnostic and quality control applications.

rapid-microbiology-testing-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 5.22 Billion
Market Forecast in 2031 (Value) USD 9.00 Billion
Growth Rate CAGR of 9.6 % from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Billion), Volume (Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product:
    • Instruments
    • Reagents & Kits
    • Consumables
  • By Method:
    • Growth-based
    • Cellular component-based
    • Nucleic acid-based
    • Viability-based
    • Other Methods
  • By Application:
    • Industrial Testing
    • Clinical Disease Diagnosis
    • Research Applications
  • By End User:
    • Hospitals
    • Clinical Laboratories
    • & ASCs; Pharmaceutical & Biotechnology Companies; Food & Beverage Companies; Environmental & Water Testing Laboratories; Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

WHAT IS IN IT FOR YOU: RAPID MICROBIOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

rapid-microbiology-testing-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Country-wise analysis of rapid microbiology testing market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa Detailed analysis and profiling of up to five additional market players
  • Expanded competitive landscape assessment with profiling and analysis of 25 key companies operating in the rapid microbiology testing market
  • Highlighting recent product developments, strategic investments, partnerships, and market positioning
Market share analysis and competitive benchmarking of key rapid microbiology testing companies Further breakdown of the rapid microbiology testing market into specific countries for Rest of Europe, Rest of Asia Pacific, Rest of Latin America, and Rest of Middle East & Africa Enhanced regional granularity through additional country-level segmentation, including Germany, the UK, France, Italy, Spain, and Rest of Europe; China, Japan, India, South Korea, Australia and Rest of Asia Pacific; Brazil, Mexico, and Rest of Latin America, along with dedicated analysis for the Middle East & Africa; United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa
Pricing analysis of rapid microbiology testing consumables and instruments Country-wise regulatory and reimbursement landscape analysis for rapid microbiology testing Broadened market segmentation framework with the inclusion of end user segmentation covering hospitals, clinical laboratories, & ASCs, pharmaceutical & biotechnology companies, food & beverage companies, environmental & water testing laboratories, and other end users

RECENT DEVELOPMENTS

  • April 2026 : bioMérieux SA (France) launched BIOFIRE SPOTFIRE, a rapid molecular mycoplasma testing platform for pharmaceutical QC applications, delivering results in less than one hour.
  • March 2026 : bioMérieux (France) received IVDR CE marking for near-patient respiratory and sore throat molecular diagnostic panels for rapid infectious disease detection, in about 15 minutes, across Europe.
  • December 2025 : Waters Corporation (US) expanded respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe through IVDR-certified VIASURE assays developed by Certest Biotec for use on the BD MAX System, enhancing automated molecular pathogen detection capabilities.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
30
RESEARCH METHODOLOGY
36
EXECUTIVE SUMMARY
50
PREMIUM INSIGHTS
54
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing incidence of infectious diseases and cancer
    - Technological advancements in rapid microbiology testing
    - Increased funding for R&D
    - Increased focus on early detection of infectious diseases
    RESTRAINTS
    - High capital investments and low cost-benefit ratio
    - Unfavorable regulatory and reimbursement scenario
    OPPORTUNITIES
    - Growth opportunities in emerging countries
    CHALLENGES
    - Operational barriers
  • 5.3 PRICING ANALYSIS
  • 5.4 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • 5.8 ECOSYSTEM ANALYSIS
    RAPID MICROBIOLOGY TESTING MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - China
    - Japan
    - India
    LATIN AMERICA
    - Brazil
    - Mexico
    MIDDLE EAST
    - Africa
  • 5.11 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Automated multiplex PCR systems
    COMPLEMENTARY TECHNOLOGIES
    - Optical immunosensors
    - Electrochemical immunosensors
    ADJACENT TECHNOLOGIES
    - MALDI-TOF mass spectrometry
  • 5.12 KEY CONFERENCES & EVENTS IN 2024–2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    REVENUE SHIFT & REVENUE POCKETS FOR RAPID MICROBIOLOGY TESTING MARKET
    REVENUE SHIFT IN RAPID MICROBIOLOGY TESTING MARKET
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT
81
  • 6.1 INTRODUCTION
  • 6.2 INSTRUMENTS
    AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
    - Ease of use compared to conventional identification processes to support market growth
    MASS SPECTROMETERS
    - Rapid results associated with mass spectrometry methods to boost adoption
    BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
    - Unwanted detection of non-microbial ATP to limit market adoption
    PCR SYSTEMS
    - Growing use of standard PCR, real-time PCR, and qPCR for rapid microbial testing to support growth
    CYTOMETERS
    - Ability to detect viable organisms to favor market growth
    ACTIVE AIR SAMPLERS
    - Convenience and ease of use to drive demand for active air samplers
    OTHER INSTRUMENTS
  • 6.3 REAGENTS & KITS
    STERILITY REAGENTS & KITS
    - Increasing adoption of BET assays to propel market growth
    OTHER REAGENTS & KITS
  • 6.4 CONSUMABLES
    DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
RAPID MICROBIOLOGY TESTING MARKET, BY METHOD
119
  • 7.1 INTRODUCTION
  • 7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
    GROWING DEMAND FOR GROWTH-BASED RAPID MICROBIOLOGY TESTING TO DRIVE MARKET GROWTH
  • 7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
    HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY ASSOCIATED WITH THIS METHOD TO BOOST MARKET
  • 7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
    HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
  • 7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
    NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
  • 7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION
137
  • 8.1 INTRODUCTION
    PRIMARY NOTES
    - Key industry insights
  • 8.2 INDUSTRIAL TESTING
    FOOD & BEVERAGE TESTING
    - Stringent quality control and quality assurance processes to drive market growth
    PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
    - Improved regulatory scenario for drug development to support market growth
    ENVIRONMENTAL TESTING
    - Growing focus on environmental monitoring to boost segmental growth
    COSMETICS & PERSONAL CARE PRODUCTS TESTING
    - Growing use of rapid microbiology testing in these industries to determine presence of microbes to favor market growth
    OTHER INDUSTRIAL TESTING APPLICATIONS
  • 8.3 CLINICAL DISEASE DIAGNOSIS
    HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
  • 8.4 RESEARCH APPLICATIONS
    INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH
RAPID MICROBIOLOGY TESTING MARKET, BY REGION
164
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - Increasing adoption of technologically advanced products in US to favor market growth
    CANADA
    - Favorable environment for R&D and rising incidence of infectious diseases to drive market
  • 9.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising emphasis on food testing and safety to fuel market growth
    UK
    - Increasing investments and funding by government to drive market growth
    FRANCE
    - Rising R&D expenditure to favor market growth
    ITALY
    - Increased adoption of advanced diagnostic technologies and growing government healthcare investments to drive market
    SPAIN
    - Rising geriatric population and improving healthcare infrastructure to boost market growth
    RUSSIA
    - Increasing access to quality healthcare to propel market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - Rising importance of quality control across food and pharmaceutical industries to drive market growth
    JAPAN
    - Rising geriatric population in Japan to support market growth
    INDIA
    - Increasing private and public investments in healthcare systems to drive adoption of rapid microbiology testing products
    AUSTRALIA
    - Increasing awareness about antimicrobial resistance to fuel market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Improving healthcare infrastructure and stringent regulations to fuel market
    MEXICO
    - Improving accessibility and affordability of healthcare services to support market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
    MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 9.7 GCC COUNTRIES
    RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
    GCC COUNTRIES: RECESSION IMPACT
COMPETITIVE LANDSCAPE
239
  • 10.1 INTRODUCTION
  • 10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET
  • 10.3 REVENUE SHARE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
    RAPID MICROBIOLOGY TESTING MARKET
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    LIST OF EVALUATED VENDORS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • 10.7 VALUATION AND FINANCIAL METRICS OF RAPID MICROBIOLOGY TESTING VENDORS
  • 10.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
254
  • 11.1 KEY PLAYERS
    BIOMÉRIEUX SA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    BRUKER
    - Business overview
    - Products offered
    - Recent developments
    QUIDELORTHO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    SARTORIUS AG
    - Business overview
    - Products offered
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    NEOGEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    DON WHITLEY SCIENTIFIC LIMITED
    RAPID MICRO BIOSYSTEMS, INC.
    GRADIENTECH
    PERKINELMER INC.
    RQMICRO AG
    COLIFAST AS
    SEROSEP LIMITED
    BTNX INC.
    R-BIOPHARM AG
    PARAGON GENOMICS, INC.
    KYPHA INC.
    VIVIONE BIOSCIENCES
    BACTEST LTD.
    CORDX
APPENDIX
310
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 ESTIMATED NUMBER OF NEW CANCER CASES FOR BOTH GENDERS (AGE: 0–85+), 2022 VS. 2045
  • TABLE 2 INDICATIVE PRICING FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • TABLE 3 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION
  • TABLE 4 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 5 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 6 RAPID MICROBIOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: CLASSIFICATION OF DEVICES
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS (%)
  • TABLE 15 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • TABLE 16 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 17 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 18 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 19 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 20 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 21 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 23 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 24 RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PCR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CYTOMETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ACTIVE AIR SAMPLERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR STERILITY TESTING REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 81 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
  • TABLE 82 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 108 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 109 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 156 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 157 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 160 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 161 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 162 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 165 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 166 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 172 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 173 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 176 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 177 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 178 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 181 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 182 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 183 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 186 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 187 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 188 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 191 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 192 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 193 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 196 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 197 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 198 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 201 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 206 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 213 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 214 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 217 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 218 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 219 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 222 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 223 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 224 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 227 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 228 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 229 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 232 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 234 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 238 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 240 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 244 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 245 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 248 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 249 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 250 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 253 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 254 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 255 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 260 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 263 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2022–2029 (USD MILLION)
  • TABLE 268 GCC COUNTRIES: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 269 RAPID MICROBIOLOGY TESTING MARKET: STRATEGIES ADOPTED
  • TABLE 270 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 271 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT
  • TABLE 272 RAPID MICROBIOLOGY TESTING MARKET: REGIONAL FOOTPRINT
  • TABLE 273 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT
  • TABLE 274 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/ SME PLAYERS
  • TABLE 275 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2020–JANUARY 2024
  • TABLE 276 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2020–JANUARY 2024
  • TABLE 277 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024
  • TABLE 278 BIOMÉRIEUX SA: COMPANY OVERVIEW
  • TABLE 279 BIOMÉRIEUX SA: PRODUCTS OFFERED
  • TABLE 280 BIOMÉRIEUX SA: PRODUCT LAUNCHES & APPROVALS
  • TABLE 281 BIOMÉRIEUX SA: DEALS
  • TABLE 282 BIOMÉRIEUX SA: OTHER DEVELOPMENTS
  • TABLE 283 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 284 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 285 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS
  • TABLE 286 BECTON, DICKINSON AND COMPANY: DEALS
  • TABLE 287 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 288 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 289 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 290 DANAHER CORPORATION: DEALS
  • TABLE 291 DANAHER CORPORATION: EXPANSIONS
  • TABLE 292 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 293 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 294 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
  • TABLE 295 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 296 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 297 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 298 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 299 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 300 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 301 MERCK KGAA: DEALS
  • TABLE 302 BRUKER: COMPANY OVERVIEW
  • TABLE 303 BRUKER: PRODUCTS OFFERED
  • TABLE 304 BRUKER: PRODUCT LAUNCHES
  • TABLE 305 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 306 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 307 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 308 QUIDELORTHO CORPORATION: DEALS
  • TABLE 309 QUIDELORTHO CORPORATION: OTHER DEVELOPMENTS
  • TABLE 310 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 311 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 312 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 313 CHARLES RIVER LABORATORIES: PRODUCTS OFFERED
  • TABLE 314 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES
  • TABLE 315 CHARLES RIVER LABORATORIES: DEALS
  • TABLE 316 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 317 NEOGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 318 NEOGEN CORPORATION: PRODUCT LAUNCHES
LIST OF FIGURES
 
  • FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 RAPID MICROBIOLOGY TESTING MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GROWING FOCUS ON EARLY DETECTION OF DISEASES TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
  • FIGURE 13 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 14 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 15 INDUSTRIAL TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN RAPID MICROBIOLOGY TESTING MARKET DURING FORECAST PERIOD
  • FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 PATENT ANALYSIS FOR PCR SYSTEMS (JANUARY 2014–DECEMBER 2023)
  • FIGURE 19 VALUE CHAIN ANALYSIS OF RAPID MICROBIOLOGY TESTING MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 20 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RAPID MICROBIOLOGY TESTING PRODUCTS
  • FIGURE 23 KEY BUYING CRITERIA FOR RAPID MICROBIOLOGY TESTING PRODUCTS
  • FIGURE 24 RAPID MICROBIOLOGY TESTING MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS (2018–2022)
  • FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
  • FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT
  • FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • FIGURE 32 EV/EBITDA OF KEY VENDORS
  • FIGURE 33 P/E RATIO OF KEY VENDORS
  • FIGURE 34 PRODUCT/BRAND COMPARISON: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING PRODUCTS
  • FIGURE 35 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
  • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 41 BRUKER: COMPANY SNAPSHOT (2022)
  • FIGURE 42 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 45 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)

 

Methodology

The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the rapid microbiology testing market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

Rapid Microbiology Testing Market Size, and Share

Note: C-level executives include chief executive officers (CEOs), chief financial officers (CFOs), chief operating officers (COOs), and vice presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global rapid microbiology testing market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global rapid microbiology testing market was split into various segments and subsegments:

  • List of major players in the product market by region or country
  • Product mapping of various rapid microbiology testing manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from rapid microbiology testing products (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
  • Summation of revenue of all companies to arrive at the global rapid microbiology testing market size.

Rapid Microbiology Testing Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall size of the global rapid microbiology testing market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

Market Definition

Rapid microbiology testing products are used to rapidly detect, screen, enumerate, and identify microbes and microbial contaminants causing or spreading diseases. These testing procedures include microbial methods that give sensitive and accurate results faster than conventional microbial testing methods.

Key Stakeholders

  • Manufacturers and distributors of rapid microbiology tests
  • Hospitals & clinics
  • Diagnostic centers
  • Research & development (R&D) companies
  • Clinical research organizations (CROs)
  • Research laboratories & academic institutes
  • Government associations
  • Venture capitalists and investors

Report Objectives

  • To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application, end user, and region, in terms of value
  • To estimate and forecast the market size for instruments in terms of volume
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall rapid microbiology testing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the rapid microbiology testing market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the rapid microbiology testing market and comprehensively analyze their core competencies and market shares
  • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the rapid microbiology testing market
  • To benchmark players within the rapid microbiology testing market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available customizations:

Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:

GEOGRAPHIC ANALYSIS

  • Further breakdown of the Rest of Europe's rapid microbiology testing market into Russia, Switzerland, Denmark, Austria, and others
  • Further breakdown of the Rest of Asia Pacific rapid microbiology testing market into Hong Kong, Taiwan, and others
  • Further breakdown of the Rest of Latin American rapid microbiology testing market into Argentina, Colombia, Chile, Ecuador, and others
  • Further breakdown of the Southeast Asian rapid microbiology testing market into Malaysia, Singapore, Australia, New Zealand, and others

COMPETITIVE LANDSCAPE ASSESSMENT

  • Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the rapid microbiology testing market
  • Competitive leadership mapping for established players in the US

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Rapid Microbiology Testing Market

DMCA.com Protection Status